R&D channel feed

Su­per­nus’ stock sinks af­ter place­bo ef­fect de­rails mid-stage de­pres­sion study

2 months ago

Ex­clu­sive: CRISPR de­liv­ery start­up, based on UC Berke­ley and UCSF sci­ence, shuts down

2 months ago
Startups

As part of turn­around, Sol­id Bio re­ports promis­ing ini­tial da­ta for Duchenne gene ther­a­py

2 months ago

Ar­cus touts ear­ly kid­ney can­cer da­ta as Gilead de­clines op­tion

2 months ago
Deals

French biotech’s top­i­cal pain treat­ment fails Phase 2 study with over­per­form­ing place­bo

2 months ago

Lil­ly’s ear­ly blad­der can­cer da­ta hint at safe­ty edge over J&J’s Balver­sa

2 months ago

Cor­bus shares dip on mixed Phase 1 sol­id tu­mor da­ta for Nectin-4 ADC

2 months ago

BioN­Tech vets raise $90M Se­ries A for bis­pe­cif­ic I&I start­up

2 months ago
Financing

Bris­tol My­ers’ Op­du­alag stum­bles in late-stage re­sect­ed melanoma tri­al

2 months ago

Labs fear fu­ture fund­ing cuts with Trump ad­min­is­tra­tion ac­tions in lim­bo

2 months ago
Pharma

Agios’ Pyrukynd suc­ceeds in key tri­al of rare red blood cell dis­or­der in kids

2 months ago

Sanofi faces $250M charge af­ter J&J-part­nered vac­cine flunks late-stage test

2 months ago
Deals

Novo's weight loss drug helps curb some drink­ing habits, small study shows

2 months ago

Pfiz­er wins ap­proval in new in­di­ca­tion for blood can­cer drug Ad­cetris

2 months ago
Pharma
FDA+

Anap­tys­Bio gets a mid-stage win for PD-1 drug in rheuma­toid arthri­tis

2 months ago

Ab­b­Vie pens an­oth­er T cell en­gager deal, this time with Xilio

2 months ago

Ex­clu­sive: Longevi­ty start­up tar­gets rene­gade pro­teins linked to di­a­betes and obe­si­ty

2 months ago
Financing

New CMO Di­et­mar Berg­er high­lights Gilead’s ‘unique sit­u­a­tion’ and its HIV am­bi­tions

2 months ago
People
Pharma

Spring­Works lands FDA ap­proval for nerve tu­mor treat­ment

2 months ago
Pharma
FDA+

In­ven­ti­va cuts pipeline, lays off near­ly en­tire re­search team in bid to get to Phase 3 MASH read­out

2 months ago
People

Pfiz­er’s prostate can­cer da­ta leak shows promis­ing re­sults in ear­ly-stage study

2 months ago

Mer­ck KGaA con­firms in­ter­est in ac­quir­ing can­cer biotech Spring­Works

2 months ago
Pharma

Boehringer In­gel­heim touts suc­cess in sec­ond Phase 3 lung fi­bro­sis tri­al

3 months ago

Pli­ant paus­es Phase 2b lung fi­bro­sis study af­ter safe­ty board rec­om­men­da­tion, shares plum­met

3 months ago
First page Previous page 6789101112 Next page Last page
A service from the Financial Times